Alkem Laboratories Ltd.

BSE: 539523 | NSE: ALKEM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE540L01014 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Alkem Laborato Alkem Laboratories Ltd. | BSE 5524.00 -39.80 (-0.72%) | NSE 5535.00 -31.00 (-0.56%) | Trade | Add

BSE Live

Dec 26, 16:01

5524.00 -39.80 (-0.72%)

Volume

AVERAGE VOLUME

5-Day

406

10-Day

480

30-Day

5,809

104

Prev. Close

5563.80
Open Price

5563.80

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Dec 26, 15:56

5535.00 -31.00 (-0.56%)

Volume

AVERAGE VOLUME

5-Day

47,647

10-Day

48,938

30-Day

125,733

40,414

Prev. Close

5566.00
Open Price

5539.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
5535.00 (39)

Financials

Print/Copy to Excel : Go

Balance Sheet of Alkem Laboratories (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	23.91	23.91	23.91	23.91	23.91
Total Share Capital	23.91	23.91	23.91	23.91	23.91
Reserves and Surplus	11,960.96	10,268.61	9,021.38	8,613.99	7,351.70
Total Reserves and Surplus	11,960.96	10,268.61	9,021.38	8,613.99	7,351.70
Total Shareholders Funds	11,984.87	10,312.06	9,045.29	8,637.90	7,376.73
Minority Interest	448.76	402.34	389.71	209.43	181.28
NON-CURRENT LIABILITIES
Long Term Borrowings	310.91	40.00	0.00	9.38	34.25
Deferred Tax Liabilities [Net]	0.00	0.00	0.00	0.00	0.00
Other Long Term Liabilities	643.36	526.09	245.14	74.39	72.22
Long Term Provisions	338.22	299.86	369.36	332.75	250.73
Total Non-Current Liabilities	1,292.49	865.95	614.50	416.52	357.20
CURRENT LIABILITIES
Short Term Borrowings	751.88	1,173.97	1,307.15	2,570.74	1,635.96
Trade Payables	1,839.35	1,748.12	1,165.03	1,173.38	1,069.41
Other Current Liabilities	1,214.64	945.59	862.22	787.62	662.04
Short Term Provisions	159.11	126.87	372.75	273.60	236.64
Total Current Liabilities	3,964.98	3,994.55	3,707.15	4,805.34	3,604.05
Total Capital And Liabilities	17,691.10	15,574.90	13,756.65	14,069.19	11,519.26
ASSETS
NON-CURRENT ASSETS
Tangible Assets	2,386.15	2,408.63	2,203.25	2,287.10	2,233.93
Intangible Assets	43.05	47.41	66.41	211.54	163.66
Capital Work-In-Progress	476.55	148.40	310.27	339.48	393.28
Fixed Assets	2,977.27	2,614.61	2,592.90	2,838.12	2,790.87
Non-Current Investments	943.24	334.80	304.61	231.67	153.95
Deferred Tax Assets [Net]	1,738.25	1,514.83	1,302.50	1,309.26	1,107.91
Long Term Loans And Advances	0.00	0.00	8.02	8.02	11.04
Other Non-Current Assets	663.41	282.34	405.75	843.60	131.28
Total Non-Current Assets	6,745.28	5,163.32	5,026.95	5,633.76	4,590.44
CURRENT ASSETS
Current Investments	902.26	148.99	317.21	139.31	178.83
Inventories	2,922.41	2,661.18	2,607.53	3,005.53	2,312.44
Trade Receivables	2,466.25	2,252.81	2,132.18	1,884.60	1,607.21
Cash And Cash Equivalents	1,563.08	1,579.35	2,616.89	2,578.58	1,990.45
Short Term Loans And Advances	9.04	9.07	6.77	20.25	31.22
OtherCurrentAssets	3,082.78	3,760.18	1,049.12	807.16	808.67
Total Current Assets	10,945.82	10,411.58	8,729.70	8,435.43	6,928.82
Total Assets	17,691.10	15,574.90	13,756.65	14,069.19	11,519.26
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	995.22	210.67	410.26	425.90	449.06
BONUS DETAILS
Bonus Equity Share Capital	11.96	11.96	11.96	11.96	11.96
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	710.39	170.40	142.67	0.00	0.00
Non-Current Investments Unquoted Book Value	200.47	164.40	161.94	126.59	98.40
CURRENT INVESTMENTS
Current Investments Quoted Market Value	827.56	46.92	212.14	0.00	0.00
Current Investments Unquoted Book Value	74.70	102.07	105.06	0.00	144.83